(NOT FOR PUBLICATION)
Table 1A: Example of strategy coding
|
Period |
ID |
choice |
opponent |
Reactive strategies |
opponent (**) |
Global strategies |
opponent's |
Targeted strategies | ||||||
|
Grim |
TfT |
TfT |
Grim |
TfT |
TfT |
Grim |
TfT |
TfT | ||||||
|
1 |
7 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
0 |
16 |
0 |
0 |
0 |
|
2 |
7 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
18 |
0 |
0 |
0 |
|
3 |
7 |
1 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
9 |
0 |
0 |
0 |
|
4 |
7 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
16 |
0 |
0 |
0 |
|
5 |
7 |
0 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
16 |
1 |
1 |
0 |
|
6 |
7 |
1 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
1 |
18 |
1 |
1 |
0 |
|
7 |
7 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
18 |
1 |
0 |
1 |
|
8 |
7 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
1 |
0 |
9 |
0 |
0 |
0 |
|
9 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
1 |
9 |
0 |
0 |
0 |
|
10 |
7 |
1 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
18 |
1 |
0 |
0 |
|
11 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
1 |
0 |
9 |
0 |
0 |
0 |
|
12 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
1 |
18 |
1 |
0 |
0 |
|
13 |
7 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
16 |
1 |
0 |
1 |
|
14 |
7 |
1 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
18 |
1 |
0 |
0 |
|
15 |
7 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
9 |
0 |
0 |
0 |
|
16 |
7 |
0 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
16 |
1 |
1 |
0 |
|
17 |
7 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
0 |
0 |
16 |
1 |
0 |
1 |
|
18 |
7 |
0 |
1 |
1 |
0 |
1 |
1 |
1 |
0 |
0 |
16 |
1 |
0 |
0 |
|
19 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
9 |
0 |
0 |
0 |
|
20 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
18 |
1 |
0 |
0 |
|
21 |
7 |
1 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
0 |
18 |
1 |
0 |
0 |
|
22 |
7 |
1 |
0 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
16 |
1 |
0 |
0 |
|
23 |
7 |
0 |
0 |
1 |
1 |
0 |
0 |
1 |
1 |
0 |
16 |
1 |
1 |
0 |
|
24 |
7 |
1 |
1 |
1 |
0 |
1 |
0 |
1 |
0 |
1 |
18 |
1 |
0 |
0 |
|
25 |
7 |
0 |
1 |
1 |
0 |
0 |
0 |
1 |
0 |
0 |
9 |
0 |
0 |
0 |
Notes: (*) 1=cooperation, 0=defection, (**) 1=3 persons cooperated, 0=less than 3 persons cooperated;
TfT=tit-for-tat regressor. Experimental data from session 8, cycle 1, periods 1-25 (non-anonymous public
monitoring treatment).
45
More intriguing information
1. Partner Selection Criteria in Strategic Alliances When to Ally with Weak Partners2. TECHNOLOGY AND REGIONAL DEVELOPMENT: THE CASE OF PATENTS AND FIRM LOCATION IN THE SPANISH MEDICAL INSTRUMENTS INDUSTRY.
3. ‘I’m so much more myself now, coming back to work’ - working class mothers, paid work and childcare.
4. The name is absent
5. The name is absent
6. The name is absent
7. Personal Experience: A Most Vicious and Limited Circle!? On the Role of Entrepreneurial Experience for Firm Survival
8. The name is absent
9. GOVERNANÇA E MECANISMOS DE CONTROLE SOCIAL EM REDES ORGANIZACIONAIS
10. Importing Feminist Criticism